Optimizer III Targets Muscle Contractions To Treat Heart Failure; Enters Trial
This article was originally published in The Gray Sheet
Executive Summary
Impulse Dynamics is 80% enrolled in the U.S. pivotal trial of its Optimizer III cardiac contractility modulation therapy for the treatment of heart failure